NG
Therapeutic Areas
Bachem Pipeline
| Drug | Indication | Phase |
|---|---|---|
| Interferon β-1a | Multiple Sclerosis | Commercial |
| Various Peptide APIs | Multiple | Various |
| Oligonucleotide APIs | Various | Clinical/Commercial |
Leadership Team at Bachem
AS
Anne-Kathrin Stoller
Chief Executive Officer (CEO)
HV
Hans van Hees
Chief Operations Officer (COO)
AS
Alain Schaffter
Chief Financial Officer (CFO)
GL
Günther Loidl
Chief Technology Officer (CTO)
TW
Torsten Wöhr
Chief Commercial Officer (CCO)
KS
Kuno Sommer
Chairman of the Board
HW
Helma Wennemers
Board Member
SL
Steffen Lang
Board Member
AF
Alex Fässler
Board Member
SW
Simone Wyss Fedele
Board Member